Corticosteroid therapy. II. Complications and therapeutic indications.
D000302:Adrenal Cortex / Q000378:metabolism; D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000139:chemically induced; D003864:Depression, Chemical; D004231:Diuresis / Q000187:drug effects; D005221:Fatigue / Q000139:chemically induced; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006402:Hematologic Diseases / Q000188:drug therapy; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy; D006967:Hypersensitivity / Q000188:drug therapy; D007239:Infections / Q000150:complications / Q000188:drug therapy; D007249:Inflammation / Q000188:drug therapy; D050356:Lipid Metabolism; D008659:Metabolic Diseases / Q000139:chemically induced; D009132:Muscles / Q000187:drug effects; D009422:Nervous System Diseases / Q000188:drug therapy; D011605:Psychoses, Substance-Induced / Q000209:etiology; D012769:Shock / Q000188:drug therapy; D012867:Skin / Q000187:drug effects; D012871:Skin Diseases / Q000188:drug therapy
D000305:Adrenal Cortex Hormones